Microbot Medical Inc.
MBOT
$3.88
-$0.28-6.73%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 3.20% | -49.89% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 23.24% | -11.92% | |||
| Operating Income | -23.24% | 11.92% | |||
| Income Before Tax | -34.56% | 23.32% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -34.56% | 23.32% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -34.56% | 23.32% | |||
| EBIT | -23.24% | 11.92% | |||
| EBITDA | -23.45% | 11.69% | |||
| EPS Basic | -14.58% | 57.58% | |||
| Normalized Basic EPS | -2.39% | 52.47% | |||
| EPS Diluted | -14.58% | 57.58% | |||
| Normalized Diluted EPS | -2.39% | 52.47% | |||
| Average Basic Shares Outstanding | 17.38% | 80.84% | |||
| Average Diluted Shares Outstanding | 17.38% | 80.84% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||